<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0059">
 <label>59</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </string-name>, 
   <string-name>
    <surname>Hu</surname>
    <given-names>Y</given-names>
   </string-name>, 
   <string-name>
    <surname>Foley</surname>
    <given-names>C</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Exploring Ugi-Azide four-component reaction products for broad-spectrum influenza antivirals with a high genetic barrier to drug resistance</article-title>. 
  <source>Sci Rep</source>. 
  <year>2018 Mar 15</year>;
  <volume>8</volume>(
  <issue>1</issue>):
  <fpage>4653</fpage>.
  <pub-id pub-id-type="pmid">29545578</pub-id>
 </mixed-citation>
</ref>
